fda warning letters compounding semaglutide september 2025 Compounded " semaglutide" is not FDA-approved FDA issues 30 warning letters – Novo Nordisk protects US patients

Reference: Chang, Y., Hsieh, M.-H., Ju, P.-C., & Chang, C.-C

During the neuroinflammatory process, microglia get over-activated and oversensitive, and they can trigger the release of several cytotoxic molecules like tumor necrosis factor (TNF), pro-inflammatory cytokines (e.g., IL-1, IL-6, IL-18), and interferon- (IFN-), and oxidative metabolites (e.g., reactive nitrogen and oxygen species, and nitric oxide) [13]

They found no significant difference between the groups for onset of vascular dementia

Specific timing on your kit may vary

Friction from mask wearing can impact healing

The withdrawal period after stopping semaglutide or tirzepatide often brings appetite rebound, and a GLP-1 support supplement may help smooth that transition